110 related articles for article (PubMed ID: 31868235)
1. Transport of trans-activator of transcription (TAT) peptide in tumour tissue model: evaluation of factors affecting the transport of TAT evidenced by flow cytometry.
Ur Rahman A; Khan S; Khan M
J Pharm Pharmacol; 2020 Apr; 72(4):519-530. PubMed ID: 31868235
[TBL] [Abstract][Full Text] [Related]
2. Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide.
Saleh AF; Aojula H; Arthanari Y; Offerman S; Alkotaji M; Pluen A
J Control Release; 2010 Apr; 143(2):233-42. PubMed ID: 20060860
[TBL] [Abstract][Full Text] [Related]
3. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
5. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
6. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
7. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
8. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
10. Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides.
van den Brand D; Veelken C; Massuger L; Brock R
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1342-1349. PubMed ID: 29550289
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Peptide delivery into cells by using the synergistic effects of a cell-penetrating Peptide and a chemical drug to alter cell permeability.
Ma JL; Wang H; Wang YL; Luo YH; Liu CB
Mol Pharm; 2015 Jun; 12(6):2040-8. PubMed ID: 25886885
[TBL] [Abstract][Full Text] [Related]
12. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
13. Optimising non-viral gene delivery in a tumour spheroid model.
Mellor HR; Davies LA; Caspar H; Pringle CR; Hyde SC; Gill DR; Callaghan R
J Gene Med; 2006 Sep; 8(9):1160-70. PubMed ID: 16807955
[TBL] [Abstract][Full Text] [Related]
14. Light sheet fluorescence microscopy versus confocal microscopy: in quest of a suitable tool to assess drug and nanomedicine penetration into multicellular tumor spheroids.
Lazzari G; Vinciguerra D; Balasso A; Nicolas V; Goudin N; Garfa-Traore M; Fehér A; Dinnyés A; Nicolas J; Couvreur P; Mura S
Eur J Pharm Biopharm; 2019 Sep; 142():195-203. PubMed ID: 31228557
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
16. Image-based analysis of the size- and time-dependent penetration of polymeric micelles in multicellular tumor spheroids and tumor xenografts.
Mikhail AS; Eetezadi S; Ekdawi SN; Stewart J; Allen C
Int J Pharm; 2014 Apr; 464(1-2):168-77. PubMed ID: 24440400
[TBL] [Abstract][Full Text] [Related]
17. Avascular tumour growth dynamics and the constraints of protein binding for drug transportation.
Kazmi N; Hossain MA; Phillips RM; Al-Mamun MA; Bass R
J Theor Biol; 2012 Nov; 313():142-52. PubMed ID: 22974970
[TBL] [Abstract][Full Text] [Related]
18. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
19. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles.
Lu H; Stenzel MH
Small; 2018 Mar; 14(13):e1702858. PubMed ID: 29450963
[TBL] [Abstract][Full Text] [Related]
20. Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.
Joshi S; Cooke JRN; Ellis JA; Emala CW; Bruce JN
J Neurooncol; 2017 Dec; 135(3):497-506. PubMed ID: 28875440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
